Ionis Pharmaceuticals | IONS - Ebitda


Ionis Pharmaceuticals reported $-64.53M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Agios Pharmaceuticals USD -108.66M 11.65M Mar/2026
Alnylam Pharmaceuticals USD 245.34M 59.15M Jun/2026
Arrowhead Research USD -107.35M 164.52M Mar/2026
Astellas Pharma JPY 98.93B 84.75B Mar/2026
BioCryst Pharmaceuticals USD 51.7M 30.14M Sep/2025
BioMarin Pharmaceutical USD 146.05M 170.22M Mar/2026
Celltrion KRW 19.64B 1.85B Mar/2026
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Deva Holding AS TRY 882.9M 201.7M Sep/2023
Divis Laboratories Ltd INR 12.62B 3.28B Jun/2026
Exelixis USD 258.29M 15.43M Mar/2026
Halozyme Therapeutics USD 219.57M 197.66M Mar/2026
Ionis Pharmaceuticals USD -64.53M 135.49M Mar/2026
Kangmei Pharma CNY -12.72M 30.02M Mar/2026
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
Malin Corporation EUR -1.1M 200K Dec/2024
Medical Developments International AUD 1.78M 3.78M Dec/2024
Moderna USD -1.26B 468M Mar/2026
Nektar Therapeutics USD -38.9M 7.09M Mar/2026
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
Neurocrine Biosciences USD 193.3M 25.1M Mar/2026
Novartis USD 6.48B 1.19B Jun/2026
Omeros USD -47.96M 7.39M Sep/2023
OPKO Health USD -27.82M 103.34M Mar/2026
Organigram Holdings CAD -4.76M 10.02M Mar/2026
Pfizer USD 5.99B 5.23B Mar/2026
Pharma Mar EUR 700K 2.01M Jun/2026
PTC Therapeutics USD 61.98M 132.97M Mar/2026
Qiagen NV USD 148.09M 101.6M Mar/2026
Regeneron Pharmaceuticals USD 1.66B 695.2M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sarepta Therapeutics USD -252.2M 84.16M Dec/2025
Sartorius EUR 280.5M 13.2M Jun/2026
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
Tilray USD 8.36M 1.82M Sep/2025
Ultragenyx Pharmaceutical USD -155M 55.57M Mar/2026
Vertex Pharmaceuticals USD 1.19B 195.3M Mar/2026
Zealand Pharma A/S -379M 348.47M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M Mar/2026